Search Results - "Lujinovic, Ersan"

Abstract PO-056: Using MammaPrint to reduce the need for chemotherapy in early breast cancer during the COVID-19 pandemic by Murray, Elizabeth M., Myburgh, Ettienne J., Lujinovic, Ersan, Mittempergher, Lorenza, Robertson, Duncan J., de Jager, Josephus J., Kotze, Maritha J.

“…Introduction: With the recent worldwide outbreak of COVID-19, it became clear that certain comorbidities are associated with an increased risk of complications…”
Get full text

MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early‐stage breast cancer patients by Haan, Josien C., Bhaskaran, Rajith, Ellappalayam, Architha, Bijl, Yannick, Griffioen, Christian J., Lujinovic, Ersan, Audeh, William M., Penault‐Llorca, Frédérique, Mittempergher, Lorenza, Glas, Annuska M.

“…MammaPrint® (MP) is a 70‐gene signature that stratifies early‐stage breast cancer patients into low‐ and high risk of distant relapse. Further stratification…”
Get full text

Abstract PS6-06: The 70-gene signature (MammaPrint) accurately predicts distant breast cancer recurrence risk in patients aged ≥70 years from the population-based observational FOCUS cohort by Noordhoek, Iris, Bastiaannet, Esther, Lujinovic, Ersan, Esserman, Laura, Wesseling, Jelle, Scholten, Astrid, Schröder, Carolien P, Elias, Sjoerd, de Glas, Nienke A, Kroep, Judith R, Portielje, Johanneke EA, Kleijn, Miranda, Liefers, Gerrit-Jan J

“…Background Predicting breast cancer recurrence in patients aged ≥70 years is challenging, as they generally have more indolent tumors and a higher chance of…”
Get full text